eCoin® is a foundational technology similar to the building block compounds of major biotechnology companies. Sharing the desirable business characteristics of biotechnology such as large market, multiple assets, and low cost of goods sold to price ratio, eCoin combines the opportunity of biotechnology with limited risks of medtech. eCoin® is an investigational device only and is not approved for sale in any country.